Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID‐19: Quantification and precautions for a busy clinician
Main Authors: | Zeeshan Mansuri, Mahwish Adnan, Fatima Motiwala, Muhammad Khalid Zafar, Taranjeet Jolly, Shailesh Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Journal of Arrhythmia |
Online Access: | https://doi.org/10.1002/joa3.12393 |
Similar Items
-
QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01) -
Effects of Azithromycin and Moxifloxacin Used Alone and Concomitantly With QTc Prolonging Medications on the QTc Interval
by: Johannesmeyer, Herman, et al.
Published: (2015) -
QTc prolongation caused by amitriptyline
by: Mandić Danijela, et al.
Published: (2012-01-01) -
Problems with Bazett QTc correction in paediatric screening of prolonged QTc interval
by: Irena Andršová, et al.
Published: (2020-12-01) -
Ketamine-induced QTc interval prolongation
by: Tejinder S. Swaran Singh, et al.
Published: (2017-01-01)